NCT03572036 Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension Status COMPLETED Phase N/A
NCT03556657 MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS) Status COMPLETED Phase NA
NCT03513328 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT03492931 PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4) Status COMPLETED Phase PHASE1
NCT03492099 Assessing the Safety of Buprenorphine in People With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT03462511 Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial Status COMPLETED Phase NA
NCT03458897 Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant Status COMPLETED Phase NA
NCT03421756 Stem Cell Transplant in Patients With Severe Sickle Cell Disease Status TERMINATED Phase EARLY_PHASE1
NCT03417947 Vitamin D Supplementation in Children With Sickle Cell Disease Status COMPLETED Phase PHASE3
NCT03405688 Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors Status COMPLETED Phase NA
NCT03405402 Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization Status COMPLETED Phase NA
NCT03401112 A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia) Status COMPLETED Phase PHASE2
NCT03387033 Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD) Status TERMINATED Phase NA
NCT03376893 Epidemiology of Silent and Overt Strokes in Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03368924 Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia: Status COMPLETED Phase NA